| Literature DB >> 35173979 |
Westergaard Katrine1, Signe Baattrup Ritzel1, Krogh Caroline1, Lynning Marie1, Bergien Sofie Olsgaard1, Skovgaard Lasse1.
Abstract
OBJECTIVE: Digital tools offer new ways of collecting outcome data in intervention research. Little is known about the potentials and barriers of using such tools for outcome measurement in multiple sclerosis trials. This study aimed to examine reporting adherence and barriers experienced by people with multiple sclerosis in an intervention study using three different digital tools for outcome measurement.Entities:
Keywords: Multiple sclerosis; daily measurements; data collection; digital tools; mixed methods research
Year: 2021 PMID: 35173979 PMCID: PMC8842387 DOI: 10.1177/20552076211055552
Source DB: PubMed Journal: Digit Health ISSN: 2055-2076
Characteristics of participants.
| Participants from RCT study | Interviewed participants | |||||
|---|---|---|---|---|---|---|
| Intervention group
( | Control group
( | All
( | Intervention group
( | Control group
( | All
( | |
|
| ||||||
| Years, mean (SD) | 50.1 (6.4) | 49.4 (8.6) | 49.8 (7.5) | 49.3 (5.9) | 47.2 (7.1) | 48.3 (6.4) |
| Range | 39-62 | 34-64 | 34-64 | 39-59 | 34-55 | 34-59 |
|
| ||||||
| Male n (%) | 5 (35.7) | 6 (42.9) | 11 (39.3) | 4 (33.3) | 3 (27.3) | 7 (30.4) |
| Female n (%) | 9 (64.3) | 8 (57.1) | 17 (60.7) | 8 (66.7) | 8 (72.7) | 16 (69.6) |
|
| ||||||
| Years, mean (SD) | 9.3 (7.4) | 4.4 (3.9) | 6.9 (6.3) | 8.5 (7.6) | 4.1 (3.8) | 6.4 (6.4) |
| Range | 1-21 | 1-12 | 1-21 | 1-21 | 1-12 | 1-21 |
|
| ||||||
| Relapsing-remitting MS n (%) | 14 (100) | 8 (57.1) | 22 (78.6) | 12 (100) | 7 (63.6) | 19 (82.6) |
| Progressive MS n (%) | 0 (0.0) | 6 (42.9) | 8 (21.4) | 0 (0.0) | 4 (36.4) | 4 (17.4) |
RCT: randomized controlled trial; MS: multiple sclerosis; SD: standard deviation.
Overall reporting adherence over time.
| Week 1 (%) | Week 2 (%) | Week 3 (%) | Week 4 (%) | Week 5 (%) | Week 6 (%) | Week 7 (%) | Week 8 (%) | Average (%) | |
|---|---|---|---|---|---|---|---|---|---|
| Intervention group | 86 | 86 | 71 | 79 | 86 | 79 | 79 | 86 | 81 |
| Control group | 54 | 62 | 38 | 46 | 54 | 62 | 46 | 54 | 52 |
Figure 1.Overall reporting adherence over time.
Reporting adherence separately for the three tools.
| Intervention group (%) | Control group (%) | |
|---|---|---|
| MS PRO tool | 95 | 89 |
| Fitbit | 93 | 81 |
| FLO | 83 | 64 |
MS PRO: multiple sclerosis patient-reported outcome; FLO: Floodlight Open.
Reporting adherence over time.
| Week 1 (%) | Week 2 (%) | Week 3 (%) | Week 4 (%) | Week 5 (%) | Week 6 (%) | Week 7 (%) | Week 8 (%) | Average (%) | |
|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
| Intervention group | 93 | 100 | 93 | 93 | 93 | 93 | 93 | 100 | 95 |
| Control group | 92 | 85 | 92 | 85 | 100 | 85 | 85 | 92 | 89 |
|
| |||||||||
| Intervention group | 93 | 93 | 93 | 86 | 93 | 93 | 100 | 93 | 93 |
| Control group | 77 | 92 | 69 | 77 | 85 | 85 | 77 | 85 | 81 |
|
| |||||||||
| Intervention group | 86 | 86 | 71 | 86 | 86 | 86 | 79 | 86 | 83 |
| Control group | 77 | 69 | 62 | 62 | 62 | 62 | 62 | 62 | 64 |
MS PRO: multiple sclerosis patient-reported outcome; FLO: Floodlight Open.